Chen, F. ; Wettengel, J.M. ; Gegenfurtner, F. ; Moosmüller, J. ; Bunse, T. ; Jeske, S. ; Hagen, P. ; Ni, Y.* ; Urban, S.* ; Protzer, U.
Identification of NTCP animal orthologs supporting hepatitis B virus binding and infection.
J. Virol. 99:e0183324 (2025)
Chen, Y.-F. A. ; Mocanu, B. ; Akidil, E. ; Pich, D. ; Mautner, J. ; Sugden, B.* ; Hammerschmidt, W.
Assessing the fitness of Epstein-Barr virus following its reactivation.
J. Virol. 99:e0062625 (2025)
Hammer, E.* ; Flynn, C.* ; Rössler, J. ; Erder, J.* ; Napieralski, R.* ; Fricke, L.* ; Campbell, B.* ; Feuerherd, M. ; Esslinger, F. ; von Brunn, A. * ; Weber, T.* ; King, S.* ; Tan, S.* ; Brisson, A.R.* ; Protzer, U. ; Schricker, G.* ; Gärtner, K.* ; Ebert, G. ; Moretti, A.* ; Klein, F.* ; Knoops, K.* ; Heeren, R.* ; Hammerschmidt, W. ; Zeidler, R. ; Wilhelm, O.* ; Knolle, P.A.* ; Höchst, B.*
Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometry.
J. Virol. 99:e0118925 (2025)
Yan, W.* ; Liu, X.* ; Jiang, S.* ; Li, H.* ; Chi, W.* ; Luo, R.* ; Peng, J.* ; Jiang, F.* ; Stöger, T. ; Wajid, A.* ; Dodovski, A.* ; Gao, C.* ; Mingala, C.N.* ; Andreychuk, D.B.* ; Yin, R.*
Emergence and characterization of historically extinct virulent genotype IV Newcastle disease virus in wild and domestic birds: genetic insights, pathogenicity, and vaccine efficacy.
J. Virol.:e0164625 (2025)
Adhikary, D. ; Damaschke, J. ; Mautner, J. ; Behrends, U.
The Epstein-Barr virus major tegument protein BNRF1 is a common target of cytotoxic CD4+ T cells.
J. Virol. 94:e00284-20 (2020)
Delecluse, S.* ; Poirey, R.* ; Zeier, M.* ; Schnitzler, P.* ; Behrends, U. ; Tsai, M.H.* ; Delecluse, H.J.*
Identification and cloning of a new western Epstein-Barr virus strain that replicates efficiently in primary B cells.
J. Virol. 94:e01918-19 (2020)
Bussey, K.A.* ; Murthy, S.* ; Reimer, E.* ; Chan, B.* ; Hatesuer, B.* ; Schughart, K.* ; Glaunsinger, B.* ; Adler, H. ; Brinkmann, M.M.*
Endosomal toll-like receptors 7 and 9 cooperate in detection of murine gammaherpesvirus 68 infection.
J. Virol. 93, e01173-18 (2019)
Hu, J.* ; Protzer, U. ; Siddiqui, A.*
Revisiting hepatitis B virus: Challenges of curative therapies.
J. Virol. 93:e01032-19 (2019)
Chou, W.M. ; Mück-Häusl, M. ; Ko, C. ; Wettengel, J.M. ; Protzer, U. ; Stadler, D.
Establishment and characterization of a novel recombinant reporter HBV utilizing the Cre-lox recombination system.
J. Virol. 25, 37-37 (2018)
Delecluse, S.* ; Tsai, M.H.* ; Shumilov, A.* ; Bencun, M.* ; Arrow, S.* ; Beshirova, A.* ; Cottignies-Calamarte, A.* ; Lasitschka, F.* ; Bulut, O.C.* ; Münz, C.* ; Zeier, M.* ; Behrends, U. ; Delecluse, H.J.*
Epstein-Barr virus induces expression of the LPAM-1 integrin in B cells in vitro and in vivo.
J. Virol. 93:e01618-18 (2018)
Feuerherd, M. ; Körber, N. ; Boesecke, C.* ; Mohrmann, K.* ; Froeschl, G.* ; Ringelhan, M. ; Geisler, F.* ; Rockstroh, J.* ; Protzer, U. ; Bauer, T.
Altered HBV-specific CD4+T-cell Responses in HBV/HIV-1 Co-versus HBV Mono-infected Patients.
J. Virol. 25, 52-53 (2018)
Freudenberger, N. ; Meyer, T.* ; Groitl, P. ; Dobner, T.* ; Schreiner, S.
HAdV protein V core protein is targeted by the host SUMOylation machinery to limit essential viral functions.
J. Virol. 92:e01451-17 (2018)
Gilabert-Alarcon, C. ; Daessle, L.W.* ; Salgado-Mendez, S.O.* ; Perez-Flores, M.A.* ; Knoeller, K.* ; Kretzschmar, T.G.* ; Stumpp, C.
Effects of reclaimed water discharge in the Maneadero coastal aquifer, Baja California, Mexico.
J. Virol. 92, 121-139 (2018)
González-Hernández, M.* ; Hoffmann, M.* ; Brinkmann, C.* ; Nehls, J. ; Winkler, M.* ; Schindler, M. ; Pöhlmann, S.*
A GXXXA motif in the transmembrane domain of the Ebola virus glycoprotein is required for tetherin antagonism.
J. Virol. 92:13 e00403-18 (2018)
Hoffmann, M.* ; Nehlmeier, I.* ; Brinkmann, C.* ; Krähling, V.* ; Behner, L.* ; Moldenhauer, A.S.* ; Krüger, N.* ; Nehls, J. ; Schindler, M. ; Hoenen, T.* ; Maisner, A.* ; Becker, S.* ; Pöhlmann, S.*
Tetherin inhibits nipah Vvrus but not ebola virus replication in fruit bat cells.
J. Virol. 93:01821-18 (2018)
Karimzadeh, H. ; Kiraithe, M.M.* ; Kosinska, A. ; Glaser, M.* ; Fiedler, M.* ; Oberhardt, V.* ; Alizei, E.S.* ; Hofmann, M.* ; Mok, J.Y.* ; Nguyen, M.* ; van Esch, W.J.E.* ; Budeus, B.* ; Grabowski, J.* ; Homs, M.* ; Olivero, A.* ; Keyvani, H.* ; Rodríguez-Frías, F.* ; Tabernero, D.* ; Buti, M.* ; Heinold, A.* ; Alavian, S.M.* ; Bauer, T. ; Wiesch, J.S.z.* ; Raziorrouh, B.* ; Hoffmann, D.* ; Smedile, A.* ; Rizzetto, M.* ; Wedemeyer, H.* ; Timm, J.* ; Antes, I.* ; Neumann-Haefelin, C.* ; Protzer, U. ; Roggendorf, M.
Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells.
J. Virol. 92:13 e01891-17 (2018)
Menni, C.* ; Gudelj, I.* ; Macdonald-Dunlop, E.* ; Mangino, M.* ; Zierer, J. ; Besic, E.* ; Joshi, P.K.* ; Trbojević-Akmačić, I.* ; Chowienczyk, P.J.* ; Spector, T.D.* ; Wilson, J.F.* ; Lauc, G.* ; Valdes, A.M.*
Glycosylation profile of immunoglobulin G is cross-sectionally associated with cardiovascular disease risk score and subclinical atherosclerosis in two independent cohorts.
J. Virol. 122, 1555-1564 (2018)
Müncheberg, S. ; Hay, R.T.* ; Ip, W.H.* ; Meyer, T.* ; Weiß, C. ; Brenke, J.K. ; Masser, S. ; Hadian, K. ; Dobner, T.* ; Schreiner, S.
E1B-55K mediated regulation of RNF4 STUbL promotes HAdV gene expression.
J. Virol. 92, e00164-18 (2018)
Ning, X.* ; Luckenbaugh, L.* ; Liu, K.* ; Bruss, V. ; Sureau, C.* ; Hu, J.J.*
Common and distinct capsid and surface protein requirements for secretion of complete and genome-free hepatitis B virions.
J. Virol. 92:e00272-18 (2018)
Reichel, A.* ; Stilp, A.C.* ; Scherer, M.* ; Reuter, N.* ; Lukassen, S.* ; Kasmapour, B.* ; Schreiner, S. ; Cicin-Sain, L.* ; Winterpacht, A.* ; Stamminger, T.*
Chromatin-remodeling factor SPOC1 acts as a cellular restriction factor against human cytomegalovirus by repressing the major immediate early promoter.
J. Virol. 92:e00342-18 (2018)
Schreiber, S. ; Honz, M. ; Schiemann, M.* ; Protzer, U. ; Wisskirchen, K.
Generating CD4+T cells for the T-cell therapy of HBV infection.
J. Virol. 25, 47-47 (2018)
Stadler, D. ; Hess, J.* ; Schneider, J. ; Lasitschka, F.* ; Ringelhan, M. ; Ko, C. ; Chou, W.M. ; Wettengel, J.M. ; Unger, K.* ; Protzer, U.
Identification of ISG20 as the nuclease involved in Interferon-induced decline of HBV cccDNA.
J. Virol. 25, 17-17 (2018)
Suffner, S. ; Gerstenberg, N. ; Patra, M. ; Ruibal, P. ; Orabi, A. ; Schindler, M. ; Bruss, V.
Domains of the hepatitis B virus small surface protein S mediating oligomerization.
J. Virol. 92:e02232-17 (2018)
Albanese, M. ; Tagawa, T. ; Buschle, A. ; Hammerschmidt, W.
MicroRNAs of Epstein-Barr virus control innate and adaptive anti-viral immunity.
J. Virol. 91:e01667-16 (2017)
Inturi, R.* ; Mun, K.* ; Singethan, K. ; Schreiner, S. ; Punga, T.*
Human adenovirus infection causes cellular E3 ubiquitin ligase MKRN1 degradation involving the viral core protein pVII.
J. Virol. 92:e01154-17 (2017)
Shinde, P.V.* ; Xu, H.C.* ; Maney, S.K.* ; Kloetgen, A.* ; Namineni, S.* ; Zhuang, Y.* ; Honke, N.* ; Shaabani, N.* ; Bellora, N.* ; Doerrenberg, M.* ; Trilling, M.* ; Pozdeev, V.I.* ; van Rooijen, N.* ; Scheu, S.* ; Pfeffer, K.* ; Crocker, P.R.* ; Tanaka, M.* ; Duggimpudi, S.* ; Knolle, P. ; Heikenwalder, M.* ; Ruland, J.* ; Mak, T.W.* ; Brenner, D.* ; Pandyra, A.A.* ; Hoell, J.I.* ; Borkhardt, A.* ; Häussinger, D.* ; Lang, K.S.* ; Lang, P.A.*
Tumor necrosis factor-mediated survival of CD169+ cells promotes immune activation during vesicular stomatitis virus infection.
J. Virol. 92, DOI: 10.1128/JVI.01637-17 (2017)
Bayer, K. ; Banning, C.* ; Bruss, V. ; Wiltzer-Bach, L.* ; Schindler, M.
Hepatitis C virus is released via a non-canonical secretory route.
J. Virol. 90, 10558-10573 (2016)
Brinkmann, C.* ; Nehlmeier, I.* ; Walendy-Gnirß, K.* ; Nehls, J. ; González Hernández, M.* ; Hoffmann, M.* ; Qiu, X.* ; Takada, A.* ; Schindler, M. ; Pöhlmann, S.*
Tetherin antagonism by the Ebola virus glycoprotein requires an intact receptor-binding domain and can be blocked by GP1-specific antibodies.
J. Virol. 90, 11075-11086 (2016)
Chachage, M.* ; Pollakis, G.* ; Kuffour, E.O.* ; Haase, K.* ; Bauer, A.* ; Nadai, Y.* ; Podola, L.* ; Clowes, P.* ; Schiemann, M. ; Henkel, L. ; Hoffmann, D. ; Joseph, S.S.* ; Bhuju, S.* ; Maboko, L.* ; Sarfo, F.S.* ; Eberhardt, K.* ; Hoelscher, M.* ; Feldt, T.* ; Saathoff, E.* ; Geldmacher, C.*
CD25+ FoxP3+ memory CD4 T cells are frequent targets of HIV infection in vivo.
J. Virol. 90, 8954-8967 (2016)
Berrios, C.* ; Jung, J.U.* ; Primi, B.* ; Wang, M.* ; Pedamallu, C.* ; Duke, F.* ; Marcelus, C.* ; Cheng, J.* ; Garcea, R.L.* ; Meyerson, M.* ; DeCaprio, J.A.* ; TEDDY Study Group (Ziegler, A.-G. ; Beyerlein, A. ; Henneberger, L. ; Hummel, M. ; Hummel, S. ; Knopff, A. ; Krause, S. ; Peplow, C. ; Pflüger, M. ; Roth, R. ; Schenkel, J. ; Stock, J. ; Strauss, E. ; Warncke, K. ; Winkler, C.)
Malawi polyomavirus is a prevalent human virus that interacts with known tumor suppressors.
J. Virol. 89, 857-862 (2015)
Bürck, C.* ; Mund, A.* ; Berscheminski, J.* ; Kieweg, L.* ; Müncheberg, S. ; Dobner, T.* ; Schreiner, S.
KAP1 is a host restriction factor that promotes HAdV E1B-55K SUMO modification.
J. Virol. 90, 930-946 (2015)
Cui, X.* ; Luckenbaugh, L.* ; Bruss, V. ; Hu, J.J.*
Alteration of mature nucleocapsid and enhancement of covalently closed circular DNA formation by Hepatitis B Virus core mutants defective in complete virion formation.
J. Virol. 89, 10064-10072 (2015)
Gnirß, K.* ; Zmora, P.* ; Blazejewska, P.* ; Winkler, M.* ; Lins, A.* ; Nehlmeier, I.* ; Gärtner, S.* ; Moldenhauer, A.S.* ; Hofmann-Winkler, H.* ; Wolff, T.* ; Schindler, M. ; Pöhlmann, S.*
Tetherin sensitivity of influenza A viruses is strain specific: Role of hemagglutinin and neuraminidase.
J. Virol. 89, 9178-9188 (2015)
Gondim, M.V. ; Wiltzer-Bach, L.* ; Maurer, B.* ; Banning, C.* ; Arganaraz, E.* ; Schindler, M.
AP-2 is the crucial clathrin adaptor protein for CD4 downmodulation by HIV-1 Nef in primary infected CD4+ T cells.
J. Virol. 89, 12518-12524 (2015)
Hoh, A.* ; Heeg, M.* ; Ni, Y.* ; Schuch, A.* ; Binder, B.* ; Hennecke, N.* ; Blum, H.E.* ; Nassal, M.* ; Protzer, U. ; Hofmann, M.* ; Urban, S.* ; Thimme, R.*
HBV-infected HepG2hNTCP cells serve as a novel immunological tool to analyze the antiviral efficacy of CD8+ T cells in vitro.
J. Virol. 89, 7433-7438 (2015)
Lambelé, M.* ; Koppensteiner, H. ; Symeonides, M.* ; Roy, N.H.* ; Chan, J.* ; Schindler, M. ; Thali, M.*
Vpu is the main determinant for tetraspanin downregulation in HIV-1 infected cells.
J. Virol. 89, 3247-3255 (2015)
Orabi, A. ; Bieringer, M. ; Geerlof, A. ; Bruss, V.
An aptamer against the matrix binding domain on the hepatitis B virus capsid impairs virion formation.
J. Virol. 89, 9281-9287 (2015)
Steinbrück, L. ; Gustems, M. ; Medele, S. ; Schulz, T.F.* ; Lutter, D. ; Hammerschmidt, W.
K1 and K15 of Kaposi sarcoma-associated herpes virus are partial functional homologues of latent membrane protein 2A of Epstein-Barr virus.
J. Virol. 89, 7248-7261 (2015)
Thiele, F. ; Tao, S.* ; Zhang, Y. ; Muschaweckh, A. ; Zollmann, T.* ; Protzer, U. ; Abele, R.* ; Drexler, I.*
MVA-infected dendritic cells present CD4+ T-cell epitopes by endogenous MHC class II presentation pathways.
J. Virol. 98, 2698-2709 (2015)
Vassena, L.* ; Giuliani, E.* ; Koppensteiner, H. ; Bolduan, S. ; Schindler, M. ; Doria, M.*
HIV-1 NEF and VPU interfere with L-selectin (CD62L) cell surface expression to inhibit adhesion and signaling in infected CD4+ t lymphocytes.
J. Virol. 89, 5687-5700 (2015)
Bussey, K.* ; Reimer, E.* ; Todt, H.* ; Denker, B.* ; Gallo, A.* ; Konrad, A.* ; Ottinger, M.* ; Adler, H. ; Stürzl, M.* ; Brune, W.* ; Brinkmann, M.M.*
The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the toll-like receptor-induced proinflammatory cytokine response.
J. Virol. 88, 9245-9259 (2014)
Gabaev, I.* ; Elbasani, E.* ; Ameres, S. ; Steinbrück, L.* ; Stanton, R.* ; Döring, M.* ; Lenac Rovis, T.* ; Kalinke, U.* ; Jonjic, S.* ; Moosmann, A. ; Messerle, M.*
Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-epecific CD8 T cells.
J. Virol. 88, 14326-14339 (2014)
Price, P.J.* ; Luckow, B.* ; Torres-Domínguez, L.E.* ; Brandmüller, C.* ; Zorn, J. ; Kirschning, C.J.* ; Sutter, G.* ; Lehmann, M.H.*
Chemokine (C-C motif) receptor 1 (CCR1) is required for efficient recruitment of neutrophils during respiratory infection with Modified Vaccinia virus Ankara.
J. Virol. 88, 10840-10850 (2014)
Weber, E.* ; Finsterbusch, K.* ; Lindquist, R.* ; Nair, S.* ; Lienenklaus, S.* ; Gekara, N.O.* ; Janik, D. ; Weiss, S.* ; Kalinke, U.* ; Overby, A.K.* ; Kröger, A.*
Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local anti-viral response.
J. Virol. 88, 12202-12212 (2014)
Benhenda, S.* ; Ducroux, A.* ; Rivière, L.* ; Sobhian, B.* ; Ward, M.D.* ; Dion, S.* ; Hantz, O.* ; Protzer, U. ; Michel, M.L.* ; Benkirane, M.* ; Semmes, O.J.* ; Buendia, M.A.* ; Neuveut, C.*
Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of Hepatitis B Virus transcription.
J. Virol. 87, 4360-4371 (2013)
Lankisch, P.* ; Adler, H. ; Borkhardt, A.*
Testing for herpesvirus infection is essential in children with chromosomal-instability syndromes.
J. Virol. 87, 3616-3617 (2013)
Siegler, V.D. ; Bruß, V.
Role of transmembrane domains of hepatitis B virus small surface proteins in subviral-particle biogenesis.
J. Virol. 87, 1491-1496 (2013)
Vidy, A.* ; Sacher, T.* ; Adler, H. ; Jordan, S.* ; Koszinowski, U.H.* ; Ruzsics, Z.*
Systemic and local infection routes govern different cellular dissemination pathways during gammaherpesvirus infection in vivo.
J. Virol. 87, 4596-4608 (2013)
Kalla, M. ; Göbel, C. ; Hammerschmidt, W.
The lytic phase of Epstein-Barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.
J. Virol. 86, 447-458 (2012)
Koppensteiner, H.* ; Banning, C.* ; Schneider, C.* ; Hohenberg, H.* ; Schindler, M.
Macrophage internal HIV-1 is protected from neutralizing antibodies.
J. Virol. 86, 2826-2836 (2012)
Schneider, M. ; Ackermann, K.* ; Stuart, M.* ; Wex, C.* ; Protzer, U. ; Schatzl, H.M.* ; Gilch, S.*
Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain.
J. Virol. 86, 10112-10122 (2012)
Pascutti, M.F.* ; Rodríguez, A.M.* ; Falivene, J.* ; Giavedoni, L.* ; Drexler, I. ; Gherardi, M.M.*
Interplay between modified vaccinia virus Ankara and dendritic cells: Phenotypic and functional maturation of bystander dendritic cells.
J. Virol. 85, 5532-5545 (2011)
Ruiss, R. ; Jochum, S. ; Wanner, G.* ; Reisbach, G. ; Hammerschmidt, W. ; Zeidler, R.*
A virus-like particle-based Epstein-Barr virus vaccine.
J. Virol. 85, 13105-13113 (2011)
Arzberger, S. ; Hösel, M.* ; Protzer, U.
Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus.
J. Virol. 84, 11994-12001 (2010)
Busse, C.* ; Feederle, R.* ; Schnölzer, M.* ; Behrends, U. ; Mautner, J. ; Delecluse, H.-J.*
Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding.
J. Virol. 84, 1139-1147 (2010)
Deutsch, M.J. ; Ott, E. ; Papior, P. ; Schepers, A.
The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleus.
J. Virol. 84, 2533-2546 (2010)
Heinzelmann, K. ; Scholz, B.A. ; Nowak, A. ; Fossum, E.* ; Kremmer, E. ; Haas, J.* ; Frank, R.* ; Kempkes, B.
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.
J. Virol. 84, 12255-12264 (2010)
Iskra, S. ; Kalla, M. ; Delecluse, H.J.* ; Hammerschmidt, W. ; Moosmann, A.
Toll-like receptor agonists synergistically increase proliferation and activation of B cells by Epstein-Barr virus.
J. Virol. 84, 3612-3623 (2010)
Zhu, J.Y.* ; Strehle, M.L. ; Frohn, A.* ; Kremmer, E. ; Höfig, K.P. ; Meister, G.* ; Adler, H.
Identification and analysis of expression of novel microRNAs of murine gammaherpesvirus 68.
J. Virol. 84, 10266-10275 (2010)
Ejegod, D.* ; Sørensen, K.D.* ; Moßbrugger, I. ; Quintanilla-Martinez, L. ; Schmidt, J. ; Pedersen, F.S.*
Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element.
J. Virol. 83, 336-346 (2009)
Faumont, N.* ; Durand-Panteix, S.* ; Schlee, M. ; Grömminger, S. ; Schuhmacher, M.* ; Hölzel, M. ; Laux, G. ; Mailhammer, R. ; Rosenwald, A.* ; Staudt, L.M.* ; Bornkamm, G.W. ; Feuillard, J.*
C-Myc and Rel/NF-κB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
J. Virol. 83, 5014-5027 (2009)
Flach, B. ; Steer, B. ; Thakur, N.N. ; Haas, J.* ; Adler, H.
The M10 locus of murine gammaherpesvirus 68 contributes to both the lytic and the latent phases of infection.
J. Virol. 83, 8163-8172 (2009)
Jochmann, R.* ; Thurau, M.* ; Jung, S.* ; Hofmann, C.* ; Naschberger, E.* ; Kremmer, E. ; Harrer, T.* ; Miller, M.* ; Schaft, N.* ; Stürzl, M.*
O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter.
J. Virol. 83, 3704-3718 (2009)
Kindsmüller, K.* ; Schreiner, S.* ; Leinenkugel, F.* ; Groitl, P.* ; Kremmer, E. ; Dobner, T.*
A 49-kilodalton isoform of the adenovirus type 5 early region 1B 55-kilodalton protein is sufficient to support virus replication.
J. Virol. 83, 9045-9056 (2009)
Lehmann, M.H. ; Kastenmüller, W. ; Kandemir, J.D. ; Brandt, F. ; Suezer, Y.* ; Sutter, G.*
Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression.
J. Virol. 83, 2540-2552 (2009)
Pairan, A.* ; Bruß, V.
Functional surfaces of the hepatitis B virus capsid.
J. Virol. 83, 11616-11623 (2009)
Schön, U. ; Diem, O.C. ; Leitner, L. ; Günzburg, W.H.* ; Mager, D.L.* ; Salmons, B.* ; Leib-Mösch, C.
Human endogenous retroviral long terminal repeat sequences as cell type-specific promoters in retroviral vectors.
J. Virol. 83, 12643-12650 (2009)
Adhikary, D. ; Behrends, U. ; Feederle, R.* ; Delecluse, H.J.* ; Mautner, J.
Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles.
J. Virol. 82, 3903-3911 (2008)
Frank, O.* ; Verbeke, C.* ; Schwarz, N.* ; Mayer, J. ; Fabarius, A.* ; Hehlmann, R.* ; Leib-Mösch, C. ; Seifarth, W.*
Variable transcriptional activity of endogenous retroviruses in human breast cancer.
J. Virol. 82, 1808-1818 (2008)
le Clorennec, C.* ; Ouk, TS.* ; Youlyouz-Marfak, I.* ; Panteix, S.* ; Martin, C.C.* ; Rastelli, J.* ; Adriaenssens, E.* ; Zimber-Strobl, U. ; Coll, J.* ; Feuillard, J.* ; Jayat-Vignoles, C.*
Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.
J. Virol. 82, 6721-6733 (2008)
Lindner, S.E.* ; Zeller, K. ; Schepers, A. ; Sugden, B.*
The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency.
J. Virol. 82, 5693-5702 (2008)
Sander, G.* ; Konrad, A.* ; Thurau, M.* ; Wies, E.* ; Leubert, R.* ; Kremmer, E. ; Dinkel, H.* ; Schulz, T.* ; Neipel, F.* ; Stürzl, M.*
Intracellular localization map of human herpesvirus 8 proteins.
J. Virol. 82, 1908-1922 (2008)
Adler, H. ; Steer, B. ; Freimüller, K. ; Haas, J.*
Murine Gammaherpesvirus 68 Contains Two Functional Lytic Origins of Replication.
J. Virol. 81, 7300-7305 (2007)
Boccellato, F.* ; Anastasiadou, E.* ; Rosato, P.* ; Kempkes, B. ; Frati, L.* ; Faggioni, A.* ; Trivedi, P.*
EBNA2 Interferes with the Germinal Center Phenotype by Downregulating BCL6 and TCL1 in Non-Hodgkin's Lymphoma Cells.
J. Virol. 81, 2274-2282 (2007)
Gasteiger, G. ; Kastenmüller, W.* ; Ljapoci, R. ; Sutter, G.* ; Drexler, I.
Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus ankara vector vaccines.
J. Virol. 81, 11925-11936 (2007)
Gudima, S.* ; Meier, A.* ; Dunbrack, R.* ; Taylor, J.* ; Bruss, V.*
Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus.
J. Virol. 81, 4343-4347 (2007)
Gudima, S.* ; He, Y.* ; Meier, A.* ; Chang, J.* ; Chen, R.* ; Jarnik, M.* ; Nicolas, E.* ; Bruss, V.* ; Taylor, J.*
Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes.
J. Virol. 81, 3608-3617 (2007)
Jost, S.* ; Turelli, P.* ; Mangeat, B.* ; Protzer, U.* ; Trono, D.*
Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
J. Virol. 81, 10588-10596 (2007)
Tierney, R.* ; Nagra, J.* ; Hutchings, I. ; Shannon-Lowe, C.* ; Altmann, M. ; Hammerschmidt, W. ; Rickinson, A.B. ; Bell, A.
Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.
J. Virol. 81, 10092-10100 (2007)
Feederle, R.* ; Neuhierl, B.* ; Baldwin, G.* ; Bannert, H.* ; Hub, B.* ; Mautner, J. ; Behrends, U. ; Delecluse, H.J.*
Epstein-barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes.
J. Virol. 80, 9435-9443 (2006)
Goormachtigh, G.* ; Ouk, T.S.* ; Mougel, A.* ; Tranchand-Bunel, D.* ; Masy, E.* ; Le, Clorennec, C.* ; Feuillard, J.* ; Bornkamm, G.W. ; Auriault, C.* ; Manet, E.* ; Fafeur, V.* ; Adriaenssens, E.* ; Coll, J.*
Autoactivation of the Epstein-barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kB and JNK signaling pathways.
J. Virol. 80, 7382-7393 (2006)
Maier, S. ; Staffler, G. ; Hartmann, A. ; Höck, J. ; Henning, K.* ; Grabusic, K. ; Mailhammer, R. ; Hoffmann, R.* ; Wilmanns, M.* ; Lang, R.* ; Mages, J.* ; Kempkes, B.
Cellular target genes of Epstein-Barr virus nuclear antigen 2.
J. Virol. 80, 9761-9771 (2006)
Milosevic, S. ; Behrends, U. ; Adhikary, D. ; Mautner, J.
Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-barr virus by a novel bacterial expression cloning approach.
J. Virol. 80, 10357-10364 (2006)
Pegman, P.M.* ; Smith, S.M.* ; D'Souza, B.N.* ; Loughran, S.T.* ; Maier, S. ; Kempkes, B. ; Cahill, P.A.* ; Simmons, M.J.* ; Gelinas, C.* ; Walls, D.*
Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJk-dependent pathway.
J. Virol. 80, 8133-8144 (2006)
Schormann, W.* ; Kraft, A.* ; Ponsel, D.* ; Bruss, V.*
Hepatitis B virus particle formation in the absence of pregenomic RNA and reverse transcriptase.
J. Virol. 80, 4187-4190 (2006)
Stengel, A. ; Roos, C.* ; Hunsmann, G.* ; Seifarth, W.* ; Leib-Mösch, C. ; Greenwood, A.D.
Expression profiles of endogenous in Old World Monkeys.
J. Virol. 80, 4415-4421 (2006)
Stengel, A. ; Roos, C.* ; Hunsmann, G.* ; Seifarth, W.* ; Leib-Mösch, C. ; Greenwood, A.D.
Expression profiles of endogenous retroviruses in Old World monkeys.
J. Virol. 80, 4415-4421 (2006)
Frank, O.* ; Giehl, M.* ; Zheng, C.* ; Hehlmann, R.* ; Leib-Mösch, C. ; Seifarth, W.*
Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders.
J. Virol. 79, 10890-10901 (2005)
Kelly, G.K.* ; Milner, A.E.* ; Tierney, R.J.* ; Croom-Carter, D.S.G.* ; Altmann, M. ; Hammerschmidt, W. ; Bell, A.I.* ; Rickinson, A.B.*
Epstein-barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A,-3B and -3C expression in burkitt's lymphoma cells and with increased resistance to apoptosis.
J. Virol. 79, 10709-10717 (2005)
Kluge, B.* ; Schläger, M.* ; Pairan, A.* ; Bruss, V.*
Determination of the minimal distance between the matrix and transmembrane domains of the large hepatitis B virus envelope protein.
J. Virol. 79, 7918-7921 (2005)
Ludwig, H.* ; Mages, J.* ; Staib, C. ; Lehmann, M.H. ; Lang, R.* ; Sutter, G.
Role of viral factor E3L in modified vaccinia virus Ankara infection of human HeLa cells: Regulation of the virus life cycle and identification of differentially expressed host genes.
J. Virol. 79, 2584-2596 (2005)
Maier, S. ; Santak, M. ; Mantik, A. ; Grabusic, K. ; Kremmer, E. ; Hammerschmidt, W. ; Kempkes, B.
A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent.
J. Virol. 79, 8784-8792 (2005)
Najjar, I.* ; Schlee, M. ; Bornkamm, G.W.
Latent membrane protein 1 regulates STAT1 through NF-kB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells.
J. Virol. 79, 4936-4943 (2005)
Nielsen, A.A.* ; Sorensen, A.B.* ; Schmidt, J. ; Pedersen, F.S.*
Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomaganesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
J. Virol. 79, 67-78 (2005)
Peng, R.* ; Moses, S.C.* ; Tan, J.* ; Kremmer, E. ; Ling, P.D.*
The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
J. Virol. 79, 4492-4505 (2005)
Seifarth, W.* ; Frank, O.* ; Zeilfelder, U.* ; Spiess, B.* ; Greenwood, A.D.* ; Hehlmann, R.* ; Leib-Mösch, C.
Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray.
J. Virol. 79, 341-352 (2005)
Shin, E.C.* ; Protzer, U.* ; Untergasser, A.* ; Feinstone, S.M.* ; Rice, C.M.* ; Hasselschwert, D.* ; Rehermann, B.*
Liver-directed gamma interferon gene delivery in chronic hepatitis C.
J. Virol. 79, 13412-13420 (2005)
Smulevitch, S.* ; Michalowski, D.* ; Zolutukhin, A.S.* ; Schneider, R. ; Bear, J.* ; Roth, P.* ; Pavlakis, G.N.* ; Felber, B.K.*
Structural and functional analysis of the RNA transport element, a member of an extensive family present in the mouse genome.
J. Virol. 79, 2356-2365 (2005)
Gordadze, A.V.* ; Onunwor, C.W.* ; Peng, R.S.* ; Poston, D.* ; Kremmer, E. ; Ling, P.D.*
EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.
J. Virol. 78, 3919-3929 (2004)
Lee, J.M.* ; Lee, K.-H.* ; Farrell, C.J.* ; Ling, P.D.* ; Kempkes, B. ; Park, J.H.* ; Hayward, S.D.*
EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli.
J. Virol. 78, 12694-12697 (2004)
Ruvolo, V.* ; Sun, L.* ; Howard, K.* ; Sung, S.* ; Delecluse, H.-J.* ; Hammerschmidt, W. ; Swaminathan, S.*
Functional analysis of Epstein-Barr virus SM protein: Identification of amino acids essential for structure, transactivation, splicing inhibition and virion production.
J. Virol. 78, 2-13 (2004)
Schlee, M. ; Krug, T.* ; Gires, O. ; Zeidler, R.* ; Hammerschmidt, W. ; Mailhammer, R. ; Laux, G. ; Sauer, G.* ; Lovric, J.* ; Bornkamm, G.W.
Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: Activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary b cells by EBV.
J. Virol. 78, 3941-3952 (2004)
Stewart, J.P.* ; Silvia, O.J.* ; Atkin, I.M.D.* ; Hughes, D.J.* ; Ebrahimi, B.* ; Adler, H.
In vivo function of a gammaherpesvirus virion glycoprotein: Influence on B-cell infection and mononucleosis.
J. Virol. 78, 10449-10459 (2004)
Sørensen, K.D.* ; Quintanilla-Martinez, L. ; Kunder, S. ; Schmidt, J. ; Pedersen, F.S.*
Mutation of all runx (AML1/Core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
J. Virol. 78, 13216-13231 (2004)
Zhang, Z.* ; Protzer, U.* ; Hu, Z.* ; Jacob, J.* ; Liang, T.J.*
Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner.
J. Virol. 78, 4566-4572 (2004)
Brinkmann, M.M.* ; Glenn, M.* ; Rainbow, L.* ; Kieser, A. ; Henke-Gendo, C.* ; Schulz, T.H.*
Activation of Mitogen-Activated Protein Kinase and NF-kB Pathways by a Kaposi's Sarcoma- Associated Herpesvirus K15 Membrane Protein.
J. Virol. 77, 9346-9358 (2003)
Dudziak, D. ; Kieser, A. ; Dirmeier, U. ; Nimmerjahn, F.* ; Berchtold, S.* ; Steinkasserer, A.* ; Marschall, G.* ; Hammerschmidt, W. ; Laux, G. ; Bornkamm, G.W.
Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-kB Signaling Pathway.
J. Virol. 77, 8290-8298 (2003)
Herzer, K.* ; Falk, C.S. ; Encke, J.* ; Eichhorst, S.T.* ; Ulsenheimer, A.* ; Seliger, B.* ; Krammer, P.H.*
Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity.
J. Virol. 77, 8299-8309 (2003)
Hornemann, S. ; Harlin, O.* ; Staib, C. ; Kisling, S. ; Erfle, V. ; Kaspers, B.* ; Häcker, G.* ; Sutter, G.
Replication of Modified Vaccinia Virus Ankara in Primary Chicken Embryo Fibroblasts Requires Expression of the Interferon Resistance Gene E3L.
J. Virol. 77, 8394-8407 (2003)
Klöcker, U.* ; Oberwinkler, H.* ; Kürschner, T.* ; Protzer, U.*
Presence of replicating virus in recombinant hepadnavirus stocks results from recombination and can be eliminated by the use of a packaging cell line.
J. Virol. 77, 2873-2881 (2003)
Öhlschläger, P.* ; Osen, W.* ; Dell, K.* ; Faath, S.* ; Garcea, R.L.* ; Jochmus, I.* ; Müller, M.* ; Pawlita, M.* ; Schäfer, K.* ; Sehr, P.* ; Staib, C. ; Sutter, G. ; Gissmann, L.*
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.
J. Virol. 77, 4635-4645 (2003)
Ponsel, D.* ; Bruss, V.*
Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation.
J. Virol. 77, 416-422 (2003)
Vogel, T.U.* ; Reynolds, M.R.* ; Fuller, D.H.* ; Vielhuber, K.* ; Shipley, T.* ; Fuller, J.T.* ; Kunstman, K.J.* ; Sutter, G. ; Marthas, M.L.* ; Erfle, V. ; Wolinsky, S.M.* ; Wang, C.* ; Allison, D.B.* ; Rud, E.W.* ; Wilson, N.* ; Montefiori, D.* ; Altman, J.D.* ; Watkins, D.I.*
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
J. Virol. 77, 13348-13360 (2003)
Allen, T.M.* ; Mortara, L.* ; Mothe, B.R.* ; Liebl, M.* ; Jing, P.* ; Calore, B.* ; Piekarczyk, M.* ; Rudersdorf, R.* ; O'Connor, D.H.* ; Wang, X.* ; Wang, C.* ; Allison, D.B.* ; Altman, J.D.* ; Sette, A.* ; Desrosiers, R.C.* ; Sutter, G. ; Watkins, D.I.*
Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 Replication.
J. Virol. 76, 4108-4112 (2002)
Gruffat, H.* ; Batisse, J.* ; Pich, D. ; Neuhierl, W. ; Manet, E.* ; Hammerschmidt, W. ; Sergeant, A.*
Epstein-Barr Virus mRNA Export Factor EB2 is Essential for Production of Infectious Virus.
J. Virol. 76, 9635-9644 (2002)
Guérin, J.-L.* ; Gelfi, J.* ; Boullier, S.* ; Delverdier, M.* ; Bellanger, F.-A.* ; Bertagnoli, S.* ; Drexler, I. ; Sutter, G. ; Messud-Petit, F.*
Myxoma Virus Leukemia-Associated Protein is Responsible for Major Histocompatibility Complex Class I and Fas-CD95 Down-Regulation and Defines Scrapins, a New Group of Surface Cellular Receptor Abductor Proteins.
J. Virol. 76, 2912-2923 (2002)
Horton, H.* ; Vogel, T.U.* ; Carter, D.K.* ; Vielhuber, K.* ; Fuller, D.H.* ; Shipley, T.* ; Fuller, J.T.* ; Kunstmann, K.J.* ; Sutter, G. ; Montefiori, D.C.* ; Erfle, V. ; Desrosiers, R.C.* ; Wilson, N.*
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
J. Virol. 76, 7187-7202 (2002)
Ried, M.U.* ; Girod, A.* ; Leike, K.* ; Buning, H.* ; Hallek, M.
Adeno-Associated Virus Capsids Displaying Immunoglobulin-Binding Domains Permit Antibody- Mediated Vector Retargeting to Specific Cell Surface Receptors.
J. Virol. 76, 4559-4566 (2002)
Nappi, F.* ; Schneider, R. ; Zolutukhin, A.* ; Smulevitch, S.* ; Michalowski, D.* ; Bear, J.* ; Felber, B.K.* ; Pavlakis, G.N.*
Identification of a novel posttranscriptional regulatory element by using a rev- and RRE-mutated human immunodeficiency virus type 1 DNA proviral clone as a molecular trap.
J. Virol. 75, 4558-4569 (2001)
Rimessi, P.* ; Bonaccorsi, A.* ; Stürzl, M. ; Fabris, M.* ; Brocca-Cofano, E.* ; Caputo, A.* ; Melucci-Vigo, G.* ; Falchi, M.* ; Cafaro, A.* ; Cassai, E.* ; Ensoli, B.* ; Monini, P.*
Transcription Pattern of Human Herpesvirus 8 Open Reading Frame K3 in Primary Effusion Lymphoma and KaposiS Sarcoma.
J. Virol. 75, 7161-7174 (2001)
Janz, A. ; Oezel, M.* ; Kurzeder, C. ; Mautner, J. ; Pich, D. ; Kost, M. ; Hammerschmidt, W. ; Delecluse, H.-J.
Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.
J. Virol. 74, 10142-10152 (2000)
Strobl, L.J. ; Höfelmayr, H. ; Marschall, G. ; Brielmeier, M. ; Bornkamm, G.W. ; Zimber-Strobl, U.
Activated Notch1 modulates gene expression in B cells similary to Epstein-Barr viral nuclear antigen 2.
J. Virol. 74, 1727-1735 (2000)
Ludwig, E. ; Silberstein, F.C. ; van Empel, J. ; Erfle, V. ; Neumann, M. ; Brack-Werner, R.
Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes.
J. Virol. 73, 8279-8289 (1999)
Nevels, M.* ; Täuber, B.* ; Kremmer, E. ; Spruss, T.* ; Wolf, H.* ; Dobner, T.*
Transforming potential of the adenovirus type 5 E4orf3 protein.
J. Virol. 73, 1591-1600 (1999)
Baumann, M. ; Mischak, H. ; Dammeier, S. ; Kolch, W. ; Gires, O. ; Pich, D. ; Zeidler, R. ; Delecluse, H.-J. ; Hammerschmidt, W.
Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.
J. Virol. 72, 8105-8114 (1998)
Kempkes, B. ; Pich, D. ; Zeidler, R. ; Sugden, B.* ; Hammerschmidt, W.
Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.
J. Virol. 69, 231-238 (1995)
Meitinger, C. ; Strobl, L.J. ; Marschall, G. ; Bornkamm, G.W. ; Zimber-Strobl, U.
Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2- mediated transactivation and interaction of EBNA2 with its responsive element.
J. Virol. 68, 7497-7506 (1994)
Bornkamm, G.W. ; Delecluse, H.-J. ; Hammerschmidt, W. ; Bullerdiek, J.
Episomal and Integrated Copies of Epstein-Barr Virus Coexist in Burkitt Lymphoma Cell Lines.
J. Virol. 67, 1292-1299 (1993)
Delecluse, H.J. ; Bartnizke, S.* ; Hammerschmidt, W. ; Bullerdiek, J.O.* ; Bornkamm, G.W.
Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines.
J. Virol. 67, 1292-1299 (1993)
Delecluse, H.J. ; Hammerschmidt, W.
Status of Marek's disease virus in established lymphoma cell lines: Herpesvirus integration is common.
J. Virol. 67, 82-92 (1993)
Schepers, A. ; Pich, D. ; Mankertz, J. ; Hammerschmidt, W.
Cis-acting Elements in the Lytic Origin of DNA Replication of Epstein-Barr Virus.
J. Virol. 67, 4237-4245 (1993)
Schepers, A. ; Pich, D. ; Mankertz, J. ; Hammerschmidt, W.
cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus.
J. Virol. 67, 4237-4245 (1993)
Hoffmann-Fezer, G. ; Thum, J. ; Ackley, C.D.* ; Herbold, M. ; Mysliwietz, J. ; Thefeld, S. ; Hartmann, K.I.* ; Kraft, W.*
Decline in CD4+ cell numbers in cats with naturally acquired feline immunodeficiency virus infection.
J. Virol. 66, 1484-1488 (1992)
Zimber-Strobl, U. ; Suentzenich, K.-O. ; Laux, G. ; Eick, D. ; Cordier, M. ; Calender, A. ; Billaud, M. ; Lenoir, G.M. ; Bornkamm, G.W.
Epstein-Barr Virus Nuclear Antigen 2 Activates Transcription of the Terminal Protein Gene.
J. Virol. 65, 415-423 (1991)
Cordier, M. ; Calender, A. ; Billaud, M. ; Zimber-Srobl, U. ; Rousselet, G. ; Pavlish, O. ; Banchereau, J. ; Tursz, T. ; Bornkamm, G.W. ; Lenoir, G.M.
Stable Transfection of Epstein-Barr Virus (EBV) Nuclear Antigen 2 in Lymphoma Cells Containing the EBV P3HR1 Genome Induces Expression of B-Cell Activation Molecules CD21 and CD23.
J. Virol. 64, 1002-1013 (1990)
Frech, B. ; Zimber-Strobl, U. ; Suentzenich, K.-O. ; Pavlish, O. ; Lenoir, G.M. ; Bornkamm, G.W. ; Müller-Lantzsch, N.
Identification of Epstein-Barr Virus Terminal Protein 1 (TP1) in Extracts of Four Lymphoid Cell Lines, Expression in Insect Cells, and Detection of Antibodies in Human Sera.
J. Virol. 64, 2759-2767 (1990)
Rowe, D.T. ; Hall, L. ; Joab, I. ; Laux, G.
Identification of the Epstein-Barr Virus Terminal Protein Gene Products in Latently Infected Lymphocytes.
J. Virol. 64, 2866-2875 (1990)
Salmons, B. ; Erfle, V. ; Brem, G. ; Günzburg, W.H.
naf, a Trans-regulating Negative Acting Factor Encoded within the Mouse Mammary Tumour Virus 0RF Region.
J. Virol. (1990)
Salmons, B.* ; Erfle, V.F. ; Brem, G.* ; Günzburg, W.H.
Naf, a trans-regulating negative-acting factor encoded within the mouse mammary tumor virus open reading frame region.
J. Virol. 64, 6355-6359 (1990)
Bode, W.
Regulation of late functions in Salmonella bateriophages P22 and L studied by assaying endolysin synthesis.
J. Virol. 32, 1-7 (1979)